NAPRELAN (naproxen sodium) by Lavipharm is analgesic, anti-inflammatory, and antipyretic properties. First approved in 1996.
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
NAPRELAN is an extended-release oral tablet formulation of naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID) approved in 1996. It provides analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes and reducing prostaglandin synthesis. Patients use NAPRELAN for pain relief and inflammation reduction across multiple indications.
Mature product approaching loss of exclusivity with minimal Part D penetration signals declining team size and reduced marketing investment.
analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of naproxen sodium, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2). Naproxen sodium is a potent inhibitor of prostaglandin synthesis in vitro .…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain
A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain
A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo
Worked on NAPRELAN at Lavipharm? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on NAPRELAN offers limited career growth; the product's LOE-approaching lifecycle suggests minimal headcount expansion and marketing budget constraints. Career value lies in managing mature product rationalization and portfolio transition rather than product growth or innovation.